Association of Adaptive Early Phase Study Design and Late Phase Study Results in Oncology
This quantitative study assessed the association of the design methods used for early phase oncology studies (adaptive versus traditional) and the outcome of late stage clinical trials. Differences by cancer type and by drug classification were also assessed. The theoretical and conceptual framework...
Main Author: | Levy, Donna Elise |
---|---|
Format: | Others |
Language: | en |
Published: |
ScholarWorks
2019
|
Subjects: | |
Online Access: | https://scholarworks.waldenu.edu/dissertations/7029 https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=8308&context=dissertations |
Similar Items
-
On the designs of early phase oncology studies
by: Ananthakrishnan, Revathi Nayantara
Published: (2018) -
First-in-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites
by: Marc Salzberg
Published: (2012-04-01) -
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method
by: Bernard North, et al.
Published: (2019-06-01) -
Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies
by: G. D. James, et al.
Published: (2021-01-01) -
Research biopsies in the context of early phase oncology studies: clinical and ethical considerations
by: Matilde Saggese, et al.
Published: (2013-08-01)